NCT04181996View on ClinicalTrials.gov

Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine

PHASE3RecruitingINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

August 14, 2024

Study Completion Date

August 14, 2025

Conditions
Cardiovascular DiseasesAtherosclerosisInflammationDiabetes
Interventions
DRUG

Colchicine Oral Product

Patients will be randomized to receive either placebo or colchicine

DRUG

Placebo oral capsule

Patents will be randomized to receive either placebo or colchicine

Trial Locations (2)

T6G 2B7

RECRUITING

Mazankowski Alberta Heart Institute, Edmonton

K1Y 4W7

RECRUITING

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Ottawa Heart Institute Research Corporation

OTHER